Science Explorer Back to mapMap
Discussion
Company · Winchester · United Kingdom

Pierre Fabre (United Kingdom)

pierre-fabre.com/enROR OpenAlex
Research works
14
▼ 14% vs 2018-21
Citations
185
12.9 per fractional work
Top-10% rate
2.2%
all institutions 10.0%
Open access
32%
world 40%
International
79%
world 18%
Pierre Fabre (United Kingdom)

Not ranked overall: Pierre Fabre (United Kingdom) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Pierre Fabre (United Kingdom) work in?

In all years, 55% of research at Pierre Fabre (United Kingdom) is in Health Sciences, 33% in Life Sciences. Its largest fields are Medicine (41%), Immunology and Microbiology (12%), Health Professions (12%). It does 1.7× the world's share of Health Sciences.

Health Sciences: 8 fractional works · 54.8% of its workMedicine: 6 fractional works · 41.1% of its workDermatology: 3 fractional works · 18.5% of its workPharmacology: 1 fractional works · 5.8% of its workPulmonary and Respiratory Medicine: 1 fractional works · 3.8% of its workInfectious Diseases: 0 fractional works · 2.3% of its workOncology: 0 fractional works · 1.8% of its workUrology: 0 fractional works · 1.5% of its workEpidemiology: 0 fractional works · 1.3% of its workPhysiology: 0 fractional works · 1.3% of its workComplementary and alternative medicine: 0 fractional works · 1.2% of its workPathology and Forensic Medicine: 0 fractional works · 0.7% of its workRehabilitation: 0 fractional works · 0.6% of its workImmunology and Allergy: 0 fractional works · 0.5% of its workPsychiatry and Mental health: 0 fractional works · 0.5% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 0.5% of its workGenetics: 0 fractional works · 0.4% of its workGeriatrics and Gerontology: 0 fractional works · 0.3% of its workNeurology: 0 fractional works · 0.3% of its workSurgery: 0 fractional works · 0.2% of its workHealth Professions: 2 fractional works · 12.0% of its workComplementary and Manual Therapy: 1 fractional works · 6.9% of its workGeneral Health Professions: 1 fractional works · 4.4% of its workSpeech and Hearing: 0 fractional works · 0.6% of its workDentistry: 0 fractional works · 1.7% of its workPeriodontics: 0 fractional works · 1.7% of its workLife Sciences: 5 fractional works · 32.8% of its workImmunology and Microbiology: 2 fractional works · 12.4% of its workImmunology: 2 fractional works · 12.4% of its workBiochemistry, Genetics and Molecular Biology: 2 fractional works · 10.8% of its workMolecular Biology: 1 fractional works · 5.4% of its workCell Biology: 0 fractional works · 1.9% of its workGenetics: 0 fractional works · 1.6% of its workBiotechnology: 0 fractional works · 1.2% of its workCancer Research: 0 fractional works · 0.3% of its workPhysiology: 0 fractional works · 0.3% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 8.5% of its workPharmaceutical Science: 1 fractional works · 5.0% of its workPharmacology: 0 fractional works · 3.5% of its workAgricultural and Biological Sciences: 0 fractional works · 1.2% of its workFood Science: 0 fractional works · 1.2% of its workPhysical Sciences: 1 fractional works · 9.2% of its workComputer Science: 1 fractional works · 5.2% of its workComputer Networks and Communications: 0 fractional works · 3.5% of its workHuman-Computer Interaction: 0 fractional works · 1.7% of its workEnvironmental Science: 0 fractional works · 1.2% of its workPollution: 0 fractional works · 0.8% of its workHealth, Toxicology and Mutagenesis: 0 fractional works · 0.4% of its workChemistry: 0 fractional works · 0.8% of its workSpectroscopy: 0 fractional works · 0.8% of its workEngineering: 0 fractional works · 0.8% of its workIndustrial and Manufacturing Engineering: 0 fractional works · 0.8% of its workMaterials Science: 0 fractional works · 0.8% of its workBiomaterials: 0 fractional works · 0.8% of its workPhysics and Astronomy: 0 fractional works · 0.5% of its workNuclear and High Energy Physics: 0 fractional works · 0.5% of its workSocial Sciences: 0 fractional works · 3.2% of its workArts and Humanities: 0 fractional works · 1.3% of its workPhilosophy: 0 fractional works · 1.3% of its workEconomics, Econometrics and Finance: 0 fractional works · 1.3% of its workEconomics and Econometrics: 0 fractional works · 1.3% of its workBusiness, Management and Accounting: 0 fractional works · 0.4% of its workStrategy and Management: 0 fractional works · 0.4% of its workSocial Sciences: 0 fractional works · 0.1% of its workALL ITS WORKPierre Fabre(United Kingdom)14fractional works, all years
Life Sciences33%Physical Sciences9%Health Sciences55%Social Sciences3%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 17 fields, with their numbers
    1. Medicine641.1%
    2. Health Professions212.0%
    3. Dentistry01.7%
    1. Immunology and Microbiology212.4%
    2. Biochemistry, Genetics and Molecular Biology210.8%
    3. Pharmacology, Toxicology and Pharmaceutics18.5%
    4. Agricultural and Biological Sciences01.2%
    1. Computer Science15.2%
    2. Environmental Science01.2%
    3. Chemistry00.8%
    4. Engineering00.8%
    5. Materials Science00.8%
    6. Physics and Astronomy00.5%
    1. Arts and Humanities01.3%
    2. Economics, Econometrics and Finance01.3%
    3. Business, Management and Accounting00.4%
    4. Social Sciences00.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 1.02× its world share, 0 worksBiochemistry, Geneti…Pharmacology, Toxicology and Pharmaceutics: 46.81× its world share, 1 worksPharmacology, Toxico…Chemistry: 0.75× its world share, 0 worksChemistryComputer Science: 0.80× its world share, 0 worksComputer ScienceHealth Professions: 2.35× its world share, 0 worksHealth ProfessionsMedicine: 3.17× its world share, 2 worksMedicineEconomics, Econometrics and Finance: 1.51× its world share, 0 worksEconomics, Econometr…Social Sciences: 0.03× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 46.8×. Every wedge is a field page.

All 8 fields, with their numbers
  1. Pharmacology, Toxicology and Pharmaceutics46.81×1 works
  2. Medicine3.17×2 works
  3. Health Professions2.35×0 works
  4. Economics, Econometrics and Finance1.51×0 works
  5. Biochemistry, Genetics and Molecular Biology1.02×0 works
  6. Computer Science0.80×0 works
  7. Chemistry0.75×0 works
  8. Social Sciences0.03×0 works

What are the most cited papers from Pierre Fabre (United Kingdom)?

The most cited paper from Pierre Fabre (United Kingdom) is "ECCA Grading Scale: An Original Validated Acne Scar Grading Scale for Clinical Practice in Dermatology" (Brigitte Dréno, Amir Khammari, N. Orain et al., 2006), with 219 citations. Next come "Milnacipran, a new serotonin and noradrenaline reuptake inhibitor" (134) and "Analysis of Correlations between Patient-Oriented SCORAD (PO-SCORAD) and Other Assessment Scores of Atopic Dermatitis Severity and Quality of Life" (76).

Most cited papers
#PaperReleasedCitations
1 ECCA Grading Scale: An Original Validated Acne Scar Grading Scale for Clinical Practice in Dermatology Brigitte Dréno, Amir Khammari, N. Orain et al. · Dermatology 22 Dec 2006 219
2 Milnacipran, a new serotonin and noradrenaline reuptake inhibitor Alain Jacques Puech, Stuart Montgomery, J. F. Prost et al. · International Clinical Psychopharmacology Mar 1997 134
3 Analysis of Correlations between Patient-Oriented SCORAD (PO-SCORAD) and Other Assessment Scores of Atopic Dermatitis Severity and Quality of Life Christine Coutanceau, J.‐F. Stalder · Dermatology 2014 76
4 Comparative cost-minimisation of oral and intravenous chemotherapy for first-line treatment of non-small cell lung cancer in the UK NHS system K Le Lay, Eric Myon, Samuel Luke Hill et al. · The European Journal of Health Economics 27 Feb 2007 51
5 Scheduling rules to minimize total tardiness in a parallel machine problem with setup and calendar constraints Jacques Lamothe, François Marmier, Matthieu Dupuy et al. · Computers & Operations Research Open access 22 Jul 2010 34
All 55 most cited papers, with filters and sorting

Which research topics does Pierre Fabre (United Kingdom) publish most on?

By volume in 2022-now: Medical and Biological Ozone Research, Silymarin and Mushroom Poisoning, Pharmacological Effects of Natural Compounds and Mobile Health and mHealth Applications.

Medical and Biological O…0Medical and Biological Ozone Research: 0 fractional worksSilymarin and Mushroom P…0Silymarin and Mushroom Poisoning: 0 fractional worksPharmacological Effects …0Pharmacological Effects of Natural Compounds: 0 fractional worksMobile Health and mHealt…0Mobile Health and mHealth Applications: 0 fractional worksInnovative Human-Technology Interaction: 0 fractional worksPlant-based Medicinal Research: 0 fractional worksDermatology and Skin Dis…0Dermatology and Skin Diseases: 0 fractional worksAcne and Rosacea Treatments and Effects: 0 fractional worksHealthcare and Venom Research: 0 fractional worksAdvancements in Transder…0Advancements in Transdermal Drug Delivery: 0 fractional works
PharmacologyPulmonary and Respiratory MedicineGeneral Health ProfessionsHuman-Computer Interaction2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Medical and Biological Ozone Research Pharmacology 0 works
  2. 2 Silymarin and Mushroom Poisoning Pulmonary and Respiratory Medicine 0 works
  3. 3 Pharmacological Effects of Natural Compounds Pharmacology 0 works
  4. 4 Mobile Health and mHealth Applications General Health Professions 0 works
  5. 5 Innovative Human-Technology Interaction Human-Computer Interaction 0 works
  6. 6 Plant-based Medicinal Research Pharmacology 0 works
  7. 7 Dermatology and Skin Diseases Dermatology 0 works
  8. 8 Acne and Rosacea Treatments and Effects Dermatology 0 works
  9. 9 Healthcare and Venom Research Pharmacology 0 works
  10. 10 Advancements in Transdermal Drug Delivery Pharmaceutical Science 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available32.5%not open67.5%

World: 40% of research is openly available.

with international co-authors79.0%domestic only21.0%

World: 18% is written across borders.

How has Pierre Fabre (United Kingdom)'s research output changed?

Output in 2022-2025 was 14% lower than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Pierre Fabre (United Kingdom) as a percentage of every work published that year, 0.000010% in 2024.

still counting0.000050%0.00010%0.00015%Pierre Fabre (United Kingdom)0.000025% in 20251990200020102020

Fractional works of Pierre Fabre (United Kingdom) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Winchester

All research institutions in Winchester

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Pierre Fabre (United Kingdom). Posts are plain text and can be reported.